Validation of a questionnaire measuring patient knowledge of atrial fibrillation in an Asian cohort

Hoe, Rebecca Hui Min; Lin, Wanyun; Bautista, Mary Ann; Vrijhoef, Hubertus J. M.; Lim, Toon Wei

doi:10.1136/heartasia-2018-011143

Cited by 5 publications

(5 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A similar protocol was used by Bodar in the Physicians' Health Study 16 . Moreover, a disease characteristic and disease-specific treatment are among the most important factors identified in a recent questionnaire designed to measure patient knowledge of AF 37 . In the SUN cohort, the participation of university graduates (55% from health professions), and the confirmation of cases by a cardiologist minimizes the possibility of false positives.…”

Section: Discussionmentioning

confidence: 99%

Caffeinated coffee consumption and risk of atrial fibrillation in two Spanish cohorts

Bazal

Gea

Navarro

et al. 2020

European Journal of Preventive Cardiology

View full text Add to dashboard Cite

Aims The association between caffeinated coffee consumption and atrial fibrillation remains unclear. Recent studies suggest an inverse association only between a moderate caffeinated coffee consumption and atrial fibrillation, but others have reported no association. The aim of our study was to prospectively assess the association between caffeinated coffee consumption and atrial fibrillation in two Spanish cohorts, one of adults from a general population and another of elderly participants at high cardiovascular risk. Methods and results We included 18,983 and 6479 participants from the ‘Seguimiento Universidad de Navarra’ (SUN) and ‘Prevención con Dieta Mediterránea’ (PREDIMED) cohorts, respectively. Participants were classified according to their caffeinated coffee consumption in three groups: ≤3 cups/month, 1–7 cups/week, and >1 cup/day. We identified 97 atrial fibrillation cases after a median follow-up of 10.3 years (interquartile range 6.5–13.5), in the SUN cohort and 250 cases after 4.4 years median follow-up (interquartile range 2.8–5.8) in the PREDIMED study. No significant associations were observed in the SUN cohort although a J-shaped association was suggested. A significant inverse association between the intermediate category of caffeinated coffee consumption (1–7 cups/week) and atrial fibrillation was observed in PREDIMED participants with a multivariable-adjusted hazard ratio = 0.53 (95% confidence interval 0.36–0.79) when compared with participants who did not consume caffeinated coffee or did it only occasionally. No association was found for higher levels of caffeinated coffee consumption (>1 cup per day), hazard ratio = 0.79 (95% confidence interval 0.49–1.28). In the meta-analysis of both PREDIMED and SUN studies, the hazard ratio for intermediate consumption of caffeinated coffee was 0.60 (95% confidence interval 0.44–0.82) without evidence of heterogeneity. Similar findings were found for the association between caffeine intake and atrial fibrillation risk. Conclusion Intermediate levels of caffeinated coffee consumption (1–7 cups/week) were associated with a reduction in atrial fibrillation risk in two prospective Mediterranean cohorts.

show abstract

Section: Discussionmentioning

confidence: 99%

Caffeinated coffee consumption and risk of atrial fibrillation in two Spanish cohorts

Bazal

Gea

Navarro

et al. 2020

European Journal of Preventive Cardiology

View full text Add to dashboard Cite

show abstract

“…Patient-reported outcomes were measured with questionnaires validated in Singapore for both English and simplified Chinese. AF-specific QoL was measured through the Atrial Fibrillation Effect on QualiTy-of-life (AFEQT) questionnaire [25], AF knowledge through the Singapore Atrial Fibrillation Knowledge Scale (SGAFKS) [26], and patient satisfaction through the modified Patient Satisfaction Questionnaire (PSQ) [27]. Depression was screened, and its severity was quantified with the Patient Health Questionnaire (PHQ-9) [28].…”

Section: Outcome Measures and Data Collectionmentioning

confidence: 99%

A Nurse-Led Integrated Chronic Care E-Enhanced Atrial Fibrillation (NICE-AF) Clinic in the Community: A Preliminary Evaluation

Woo

Tam

Rangpa

et al. 2022

IJERPH

Self Cite

View full text Add to dashboard Cite

The current physician-centric model of care is not sustainable for the rising tide of atrial fibrillation. The integrated model of care has been recommended for managing atrial fibrillation. This study aims to provide a preliminary evaluation of the effectiveness of a Nurse-led Integrated Chronic care E-enhanced Atrial Fibrillation (NICE-AF) clinic in the community. The NICE-AF clinic was led by an advanced practice nurse (APN) who collaborated with a family physician. The clinic embodied integrated care and shifted from hospital-based, physician-centric care. Regular patient education, supplemented by a specially curated webpage, fast-tracked appointments for hospital-based specialised investigations, and teleconsultation with a hospital-based cardiologist were the highlights of the clinic. Forty-three participants were included in the six-month preliminary evaluation. No significant differences were observed in cardiovascular hospitalisations (p-value = 0.102) and stroke incidence (p-value = 1.00) after attending the NICE-AF clinic. However, significant improvements were noted for AF-specific QoL (p = 0.001), AF knowledge (p < 0.001), medication adherence (p = 0.008), patient satisfaction (p = 0.020), and depression (p = 0004). The preliminary evaluation of the NICE-AF clinic demonstrated the clinical utility of this new model of integrated care in providing safe and effective community-based AF care. Although a full evaluation is pending, the preliminary results highlighted its promising potential to be expanded into a permanent, larger-scale service.

show abstract

“…It has been demonstrated that higher levels of AF-related knowledge not only improve therapy uptake and adherence but also reduce AF-related complications such as stroke, thrombotic events, as well as health-care related costs and rate of hospitalizations [73]. Two multinational surveys showed that more than half of the patients with AF had low levels of knowledge about the increased risk of stroke related to AF or did not even know the name of their condition [192,193]. A recent European Heart Rhythm Association (EHRA) survey showed there is still room for improvement in education of patients taking OACs, mainly for NOACs [194].…”

Section: Medication Adherencementioning

confidence: 99%

“…Two multinational surveys showed that more than half of the patients with AF had low levels of knowledge about the increased risk of stroke related to AF or did not even know the name of their condition [ 192 193 ]. A recent European Heart Rhythm Association (EHRA) survey showed there is still room for improvement in education of patients taking OACs, mainly for NOACs [ 194 ].…”

Section: Anticoagulant Therapy To Prevent Af-related Strokementioning

confidence: 99%

World Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update

et al. 2021

View full text Add to dashboard Cite

The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death and disability. Atrial fibrillation (AF) is one of these conditions and is an increasing problem due to ageing of the world's population and an increase in cardiovascular risk factors that predispose to AF. The goal of the AF roadmap was to provide guidance on priority interventions that are feasible in multiple countries, and to identify roadblocks and potential strategies to overcome them.Since publication of the AF Roadmap in 2017, there have been many technological advances including devices and artificial intelligence for identification and prediction of unknown AF, better methods to achieve rhythm control, and widespread uptake of smartphones and apps that could facilitate new approaches to healthcare delivery and increasing community AF awareness.In addition, the World Health Organisation added the non-vitamin K antagonist oral anticoagulants (NOACs) to the Essential Medicines List, making it possible to increase advocacy for their widespread adoption as therapy to prevent stroke. These advances motivated the WHF to commission a 2020 AF Roadmap update. Three years after the original Roadmap publication, the identified barriers and solutions were judged still relevant, and progress has been slow.This 2020 Roadmap update reviews the significant changes since 2017 and identifies priority areas for achieving the goals of reducing death and disability related to AF, particularly targeted at low-middle income countries. These include advocacy to increase appreciation of the scope of the problem; plugging gaps in guideline management and prevention through physician education, increasing patient health literacy, and novel ways to increase access to integrated healthcare including mHealth and digital transformations; and greater emphasis on achieving practical solutions to national and regional entrenched barriers. Despite the advances reviewed in this update, the task will not be easy, but the health rewards of implementing solutions that are both innovative and practical will be great.

show abstract

Validation of a questionnaire measuring patient knowledge of atrial fibrillation in an Asian cohort

Cited by 5 publications

References 26 publications

Caffeinated coffee consumption and risk of atrial fibrillation in two Spanish cohorts

Caffeinated coffee consumption and risk of atrial fibrillation in two Spanish cohorts

A Nurse-Led Integrated Chronic Care E-Enhanced Atrial Fibrillation (NICE-AF) Clinic in the Community: A Preliminary Evaluation

World Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update

Contact Info

Product

Resources

About